Literature DB >> 20452174

Cost and effectiveness of postoperative fever diagnostic evaluation in total joint arthroplasty patients.

Derek T Ward1, Erik N Hansen, Steven K Takemoto, Kevin J Bozic.   

Abstract

The purpose of this study is to examine the characteristics and costs of postoperative fever diagnostic evaluations after total joint arthroplasty. All patients who underwent hip and knee arthroplasty (n = 1100) at a single institution for a 2-year period were included. Fever (temperature > or = 38.5 degrees C) occurred in 15% of patients. The rate of positive tests was as follows: chest radiograph (2%), blood culture (6%), urine culture (22%), and urinalysis (23.7%). Fever occurring after postoperative day 3 (odds ratio [OR] 23.3; P < .001) and multiple days febrile (OR, 8.6; P = .003) are independent predictors of a positive workup, and patients with a maximum temperature of 39.0 degrees C or higher (25.4% vs 6.9%; P = .001) had a significantly higher rate of positive fever evaluations. The total direct cost associated with fever evaluations was $73 878, and cost per change in clinical management was $8209. Fever is a common occurrence after hip and knee arthroplasty, and many elements of an infectious evaluation are costly and clinically unnecessary.
Copyright © 2010. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2010        PMID: 20452174     DOI: 10.1016/j.arth.2010.03.016

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  13 in total

Review 1.  [Evidence-based update in hip arthroplasty].

Authors:  H Gollwitzer; L Gerdesmeyer; R Gradinger; R von Eisenhart-Rothe
Journal:  Orthopade       Date:  2011-06       Impact factor: 1.087

2.  Fewer postoperative fevers: an unexpected benefit of multimodal pain management?

Authors:  Joseph A Karam; Benjamin Zmistowski; Camilo Restrepo; William J Hozack; Javad Parvizi
Journal:  Clin Orthop Relat Res       Date:  2014-05       Impact factor: 4.176

3.  Course of fever and potential infection after total joint replacement.

Authors:  Xin Lu; Jin Jin; Jin Lin; Wenwei Qian; Xisheng Weng
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2014-06-06       Impact factor: 4.342

Review 4.  Perioperative infection in the patient with rheumatic disease.

Authors:  Andy O Miller; Barry D Brause
Journal:  Curr Rheumatol Rep       Date:  2013-12       Impact factor: 4.592

5.  Leukocytosis is common after total hip and knee arthroplasty.

Authors:  Gregory K Deirmengian; Benjamin Zmistowski; Christina Jacovides; Joseph O'Neil; Javad Parvizi
Journal:  Clin Orthop Relat Res       Date:  2011-11       Impact factor: 4.176

6.  A retrospective controlled study of postoperative fever after posterior lumbar interbody fusion due to degenerative lumbar disease.

Authors:  Jung Jae Lee; Jeong Hee Kim; Ju Hee Jeon; Myeong Jong Kim; Byong Gon Park; Sang Ku Jung; Sang Ryong Jeon; Sung Woo Roh; Jin Hoon Park
Journal:  Medicine (Baltimore)       Date:  2022-05-20       Impact factor: 1.817

7.  A prospective evaluation of postoperative fever in adult neurosurgery patients in the COVID-19 era.

Authors:  Abhijit Goyal-Honavar; Ankush Gupta; Abi Manesh; George M Varghese; Gandham Edmond Jonathan; Krishna Prabhu; Ari G Chacko
Journal:  J Clin Neurosci       Date:  2022-07-04       Impact factor: 2.116

8.  Diagnosis of periprosthetic joint infection in Medicare patients: multicriteria decision analysis.

Authors:  Claudio Diaz-Ledezma; Paul M Lichstein; James G Dolan; Javad Parvizi
Journal:  Clin Orthop Relat Res       Date:  2014-11       Impact factor: 4.176

9.  Internal medicine residents' evaluation of fevers overnight.

Authors:  Jessica Howard-Anderson; Kristin E Schwab; Sandy Chang; Holly Wilhalme; Christopher J Graber; Roswell Quinn
Journal:  Diagnosis (Berl)       Date:  2019-06-26

10.  Characteristics and significance of fever during 4 weeks after primary total knee arthroplasty.

Authors:  Yoshinori Ishii; Hideo Noguchi; Mitsuhiro Takeda; Junko Sato; Satoshi Takayama; Shin-ichi Toyabe
Journal:  Arch Orthop Trauma Surg       Date:  2014-02-13       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.